兰瑞肽
医学
二甲双胍
哮喘
腹痛
神经内分泌肿瘤
腹泻
糖尿病
胃肠病学
生长抑素类似物
生长抑素
内科学
胰腺
奥曲肽
胰岛素
普通外科
内分泌学
激素
生长激素
肢端肥大症
作者
Ryosuke Sato,Shigeru Horiguchi,Motoyuki Otsuka
标识
DOI:10.1053/j.gastro.2023.07.012
摘要
Question: A 67-year-old man was admitted to the hospital because of a 1-month history of abdominal pain and diarrhea occurring 30 times per day. He had been undergoing treatment with the somatostatin analog lanreotide (120 mg subcutaneously every 4 weeks) for a nonfunctional pancreatic neuroendocrine tumor (NET-G3) (Figure A, arrow) with multiple liver metastases (Figure A, arrowhead) for 4 months. He also had comorbidities that included diabetes, which was being managed with insulin and metformin, and bronchial asthma requiring inhaler use.
科研通智能强力驱动
Strongly Powered by AbleSci AI